150 related articles for article (PubMed ID: 27425043)
1. Positive surgical margins contribute to the survival paradox between patients with stage IIB/C (T4N0) and stage IIIA (T1-2N1, T1N2a) colon cancer.
Chu QD; Zhou M; Medeiros K; Peddi P
Surgery; 2016 Nov; 160(5):1333-1343. PubMed ID: 27425043
[TBL] [Abstract][Full Text] [Related]
2. Poor survival in stage IIB/C (T4N0) compared to stage IIIA (T1-2 N1, T1N2a) colon cancer persists even after adjusting for adequate lymph nodes retrieved and receipt of adjuvant chemotherapy.
Chu QD; Zhou M; Medeiros KL; Peddi P; Kavanaugh M; Wu XC
BMC Cancer; 2016 Jul; 16():460. PubMed ID: 27412163
[TBL] [Abstract][Full Text] [Related]
3. Survival paradox between stage IIB/C (T4N0) and stage IIIA (T1-2N1) colon cancer.
Kim MJ; Jeong SY; Choi SJ; Ryoo SB; Park JW; Park KJ; Oh JH; Kang SB; Park HC; Heo SC; Park JG
Ann Surg Oncol; 2015 Feb; 22(2):505-12. PubMed ID: 25145501
[TBL] [Abstract][Full Text] [Related]
4. Survival paradox between stage IIB/C and stage IIIA colon cancer: is it time to revise the American Joint Committee on Cancer TNM system?
Chu QD; Li T; Hsieh MC; Yi Y; Gibbs JF; Sahawneh J; Sang W; Gallagher J; Wu XC
Surg Endosc; 2024 May; 38(5):2857-2870. PubMed ID: 38575828
[TBL] [Abstract][Full Text] [Related]
5. Laparoscopic colectomy for cancer: Improved compliance with guidelines for chemotherapy and survival.
Kim RH; Kavanaugh MM; Caldito GC
Surgery; 2017 Jun; 161(6):1633-1641. PubMed ID: 28027818
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological and biomolecular characteristics of stage IIB/IIC and stage IIIA colon cancer: Insight into the survival paradox.
Kim HS; Kim KM; Lee SB; Kim GR; Han YD; Cho MS; Hur H; Lee KY; Kim NK; Min BS
J Surg Oncol; 2019 Sep; 120(3):423-430. PubMed ID: 31134644
[TBL] [Abstract][Full Text] [Related]
7. Examining the relationship between lymph node harvest and survival in patients undergoing colectomy for colon adenocarcinoma.
Trepanier M; Erkan A; Kouyoumdjian A; Nassif G; Albert M; Monson J; Lee L
Surgery; 2019 Oct; 166(4):639-647. PubMed ID: 31399220
[TBL] [Abstract][Full Text] [Related]
8. T4N0 colon cancer has oncologic outcomes comparable to stage III in a specialized center.
Rottoli M; Stocchi L; Dietz DW
Ann Surg Oncol; 2012 Aug; 19(8):2500-5. PubMed ID: 22395999
[TBL] [Abstract][Full Text] [Related]
9. Receipt of Adjuvant Chemotherapy in Stage II Colon Cancer and Overall Survival: A National Cancer Database Study.
Enofe N; Morris AD; Liu Y; Liang W; Wu CS; Sullivan PS; Balch GG; Staley CA; Gillespie TW; Shaffer VO
J Surg Res; 2020 Aug; 252():69-79. PubMed ID: 32244127
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant chemotherapy increase survival and decrease recurrence in stage IIA colon cancer.
Yun HR; Kim HC; Yun SH; Lee WY
Hepatogastroenterology; 2012; 59(120):2466-71. PubMed ID: 23169179
[TBL] [Abstract][Full Text] [Related]
11. Survival in stage III colon cancer is independent of the total number of lymph nodes retrieved.
Tsikitis VL; Larson DL; Wolff BG; Kennedy G; Diehl N; Qin R; Dozois EJ; Cima RR
J Am Coll Surg; 2009 Jan; 208(1):42-7. PubMed ID: 19228501
[TBL] [Abstract][Full Text] [Related]
12. Controversial Issues Regarding Obligatory Adjuvant Chemotherapy for Stage IIIA Colon Cancer.
Kim CW; Kim TW; Lee JL; Park IJ; Yoon YS; Lim SB; Yu CS; Kim JC
Clin Colorectal Cancer; 2020 Dec; 19(4):e157-e163. PubMed ID: 32896486
[TBL] [Abstract][Full Text] [Related]
13. Pathologic Staging Inconsistency Between ypT4N0 (stage II) and ypT1-2N1 (stage III) After Preoperative Chemoradiotherapy and Total Mesorectal Excision in Rectal Cancer: A Multi-Institutional Study.
Lee JH; Yu M; Kim SH; Lee JH; Sung SY; Jeong BK; Jeong S; Nam TK; Jeong JU; Jang HS
Clin Colorectal Cancer; 2019 Mar; 18(1):e130-e139. PubMed ID: 30595556
[TBL] [Abstract][Full Text] [Related]
14. Should total number of lymph nodes be used as a quality of care measure for stage III colon cancer?
Wang J; Kulaylat M; Rockette H; Hassett J; Rajput A; Dunn KB; Dayton M
Ann Surg; 2009 Apr; 249(4):559-63. PubMed ID: 19300237
[TBL] [Abstract][Full Text] [Related]
15. Young age influences treatment but not outcome of colon cancer.
Quah HM; Joseph R; Schrag D; Shia J; Guillem JG; Paty PB; Temple LK; Wong WD; Weiser MR
Ann Surg Oncol; 2007 Oct; 14(10):2759-65. PubMed ID: 17593332
[TBL] [Abstract][Full Text] [Related]
16. Clinical impact of elastic laminal invasion in colon cancer: elastic laminal invasion-positive stage II colon cancer is a high-risk equivalent to stage III.
Yokota M; Kojima M; Nomura S; Nishizawa Y; Kobayashi A; Ito M; Ochiai A; Saito N
Dis Colon Rectum; 2014 Jul; 57(7):830-8. PubMed ID: 24901683
[TBL] [Abstract][Full Text] [Related]
17. Re-Evaluation of the Survival Paradox Between Stage IIB/IIC and Stage IIIA Colon Cancer.
Li H; Fu G; Wei W; Huang Y; Wang Z; Liang T; Tian S; Chen H; Zhang W
Front Oncol; 2020; 10():595107. PubMed ID: 33312954
[TBL] [Abstract][Full Text] [Related]
18. A novel data-driven prognostic model for staging of colorectal cancer.
Manilich EA; Kiran RP; Radivoyevitch T; Lavery I; Fazio VW; Remzi FH
J Am Coll Surg; 2011 Nov; 213(5):579-588, 588.e1-2. PubMed ID: 21925905
[TBL] [Abstract][Full Text] [Related]
19. Adherence to treatment guidelines and survival for older patients with stage II or III colon cancer in Texas from 2001 through 2011.
Zhao H; Zhang N; Ho V; Ding M; He W; Niu J; Yang M; Du XL; Zorzi D; Chavez-MacGregor M; Giordano SH
Cancer; 2018 Feb; 124(4):679-687. PubMed ID: 29140558
[TBL] [Abstract][Full Text] [Related]
20. Trends in lymph node excision and impact of positive lymph node ratio in patients with colectomy for primary colon adenocarcinoma: Population based study 1988 to 2011.
Garcia B; Guzman C; Johnson C; Hellenthal NJ; Monie D; Monzon JR
Surg Oncol; 2016 Sep; 25(3):158-63. PubMed ID: 27566017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
